EyePoint (EYPT) Acquisitions (2018)

EyePoint (EYPT) reported Acquisitions of $16.8 million for Q3 2018, up 200.0% sequentially from -$16.8 million in Q2 2018.

EyePoint (EYPT) Acquisitions (2018) Analysis & Trends

EyePoint (EYPT) has 1 years of Acquisitions data on file, last reported at $16.8 million in Q3 2018.

For the quarter ending Q3 2018, Acquisitions changed N/A year-over-year to $16.8 million; the trailing twelve-month figure through Sep 2019 stood at $16.8 million (up 11.33% YoY), and the FY2018 full-year result was $16.8 million, changed N/A from the prior year.
Acquisitions climbed to $16.8 million in Q3 2018, from -$16.8 million in the prior quarter.
In the past five years, Acquisitions ranged from a high of $16.8 million in Q3 2018 to a low of -$16.8 million in Q2 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	EyePoint	358.61 Mn	136.07 Mn	168,000.00	-

Download Data